Commonwealth Equity Services, LLC Myriad Genetics Inc Transaction History

Commonwealth Equity Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 06, 2018	SELL	$37.57 - $50.34 $206,447 - $276,618	-5,495 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$27.75 - $40.17 $152,486 - $220,734	5,495 New	5,495 $205,000
Q1 2018 May 14, 2018	SELL	$28.83 - $41.01 $178,832 - $254,385	-6,203 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$28.45 - $37.14 $176,475 - $230,379	6,203	6,203 $213,000

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.